|
81
|
306
|
9ri3A |
Sars-cov-2 with a bound inhibitor |
|
79
|
303
|
9rj8A |
Sars-cov-2 with a bound inhibitor |
|
79
|
301
|
9rizA |
Sars-cov-2 with a bound inhibitor |
|
88
|
306
|
9rj3A |
Sars-cov-2 with a bound inhibitor |
|
78
|
301
|
9rj7A |
Sars-cov-2 with a bound inhibitor |
|
76
|
301
|
9rj5A |
Sars-cov-2 with a bound inhibitor |
|
78
|
301
|
9rjfA |
Sars-cov-2 with a bound inhibitor |
|
89
|
301
|
9ridA |
Sars-cov-2 with a bound inhibitor |
|
75
|
301
|
9rhsA |
Structure of 3cl protease with a bound inhibitor |
|
75
|
301
|
9rjrA |
Sars-cov-2 with a bound inhibitor |
|
79
|
306
|
9ri1A |
Sars-cov-2 with a bound inhibitor |
|
25
|
115
|
9rczB |
Structure of the n-terminal domain of non-structural protein 1 (nsp1) from sars-cov-2 |
|
279
|
928
|
9pyzA |
Sars-cov-2 core polymerase complex bound to rna, araump, and utp |
|
289
|
928
|
9pz0A |
Sars-cov-2 core polymerase complex with two utp incorporation |
|
288
|
928
|
9pywA |
Sars-cov-2 nsp7, nsp8 and nsp12 bound to a primer-template pair with incorporated ara-ump |
|
82
|
305
|
9pfiA |
Crystal structure of sars-cov-2 mpro mutant p132h |
|
31
|
107
|
9pysA |
Nmr rdc refinement of the helical domain of the sars-cov-2 monomeric main protease (mproh41q,10-306) |
|
77
|
300
|
9pfhA |
Crystal structure of sars-cov-2 mpro mutant p132h with c5a |
|
52
|
182
|
9pywB |
Sars-cov-2 nsp7, nsp8 and nsp12 bound to a primer-template pair with incorporated ara-ump |
|
128
|
522
|
9q1jB |
Cryo-em structure of sars-cov-2 nsp10-nsp14 e191a mutant-t20p14-r complex |
|
54
|
182
|
9pyzB |
Sars-cov-2 core polymerase complex bound to rna, araump, and utp |
|
99
|
299
|
9p6pA |
Crystal structure of the sars-cov-2 2'-o-methyltransferase with (m7gpppa)pupu (cap-0) and s-adenosyl-l-homocysteine (sah). |
|
28
|
131
|
9q1jA |
Cryo-em structure of sars-cov-2 nsp10-nsp14 e191a mutant-t20p14-r complex |
|
28
|
73
|
9pz0C |
Sars-cov-2 core polymerase complex with two utp incorporation |
|
27
|
73
|
9pywC |
Sars-cov-2 nsp7, nsp8 and nsp12 bound to a primer-template pair with incorporated ara-ump |
|
33
|
128
|
9p6pB |
Crystal structure of the sars-cov-2 2'-o-methyltransferase with (m7gpppa)pupu (cap-0) and s-adenosyl-l-homocysteine (sah). |
|
54
|
182
|
9pz0B |
Sars-cov-2 core polymerase complex with two utp incorporation |
|
29
|
73
|
9pyzC |
Sars-cov-2 core polymerase complex bound to rna, araump, and utp |
|
106
|
349
|
9qjeA |
Usp7 covalently bound to n-(6-fluoro-3-nitropyridin-2-yl)-5-(1-methyl-1h-pyrazol-4-yl)isoquinolin-3-amine (gcl36, 7a) with partial occupancy |
|
36
|
175
|
9pytA |
Nmr rdc refinement of the catalytic domain of the sars-cov-2 monomeric main protease (mproh41q,10-306) |
|
82
|
348
|
9ny4K |
Usp21 bound to h2ak119ub nucleosome |
|
89
|
306
|
9nskA |
Room-temperature x-ray structure of sars-cov-2 main protease in complex with inhibitor bbh-3 |
|
70
|
222
|
9o4mA |
Crystal structure of ubiquitin carboxy terminal hydrolase l1 q209c mutant covalently crosslinked to ubiquitin genetically encoded with n6-(6-bromohexanoyl)-l-lysine |
|
20
|
45
|
9no1W |
Cryo-et map of the vzv capsid vertex (5-fold axis). |
|
86
|
306
|
9nslA |
Room-temperature x-ray structure of sars-cov-2 main protease in complex with with inhibitor bbh-4 |
|
88
|
305
|
9n6nA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with pomotrelvir |
|
89
|
302
|
9n6rA |
Room temperature x-ray structure of sars-cov-2 main protease in complex with ensitrelvir |
|
88
|
301
|
9n6pA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with ensitrelvir |
|
88
|
305
|
9n6jA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion |
|
83
|
305
|
9n6mA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with nirmatrelvir |
|
84
|
305
|
9n6lA |
Room temperature x-ray structure of sars-cov-2 main protease mutant d48y, p168 deletion in complex with gc373 |
|
86
|
305
|
9mvmA |
Crystal structure of sars-cov-2 main protease (mpro)in complex with inhibitor avi-3318 |
|
87
|
301
|
9mvqA |
Crystal structure of sars-cov-2 main protease (mpro) variant q192t in complex with inhibitor avi-4303 |
|
91
|
305
|
9mvoA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with inhibitor avi-4692 |
|
77
|
305
|
9mvpA |
Crystal structure of sars-cov-2 main protease (mpro)in complex with inhibitor avi-4516 |
|
89
|
305
|
9n3mA |
Sars-cov-2 mpro l50f/e166a/l167f triple mutant bound to inhibitor |
|
85
|
301
|
9mdqA |
Crystal structure of sars-cov-2 omicron main protease (mpro) complex with azapeptide inhibitor 20a |
|
76
|
302
|
9m2vA |
Crystal structure of the sars-cov-2 (covid-19) main protease with inhibitor mc12 |
|
84
|
296
|
9kgqA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
|
81
|
299
|
9kgnA |
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity |
